Gilead Sciences : Study Data Of Biktarvy In People Living With HIV Show High Effectiveness

Gilead Sciences Inc. (GILD) said that an interim results from the ongoing, multinational, observational single-arm, non-comparative real-world cohort BICSTaR study of Biktarvy in People Living With HIV showed high effectiveness and high levels of adherence.